KNOREX Partners with B2B Data Provider for AI-Driven Advertising Solutions.

Wednesday, Oct 15, 2025 9:20 am ET1min read

• KNOREX announces strategic partnership with B2B data provider.

• Combines AI-driven digital advertising with human-verified B2B data.

• Empowers sales and marketing teams with actionable insights.

• Accelerates customer acquisition and revenue expansion.

• Trusted by thousands of customers worldwide.

Sunnyvale, CA, Sep. 12, 2025 (GLOBE NEWSWIRE) — KNOREX Ltd. (NYSE American: KNRX), a leading provider of AI-driven digital advertising products and solutions, has announced a strategic partnership with a premier Business-to-Business (B2B) data provider. This collaboration aims to enhance KNOREX's offerings by integrating advanced AI with robust, human-verified B2B data.

The partnership combines KNOREX’s AI-powered cross-channel advertising and automation capabilities with the comprehensive proprietary B2B dataset provided by the partner. This integration will enable marketers to execute more precise, personalized campaigns at scale, driving customer acquisition and revenue expansion.

KNOREX XPOsm, the company's flagship AI-powered platform, will now incorporate high-quality, human-verified B2B data. This strategic alignment positions KNOREX at the forefront of the digital advertising industry, offering customers deeper insights and smarter targeting capabilities.

Justin Tan, VP of Business Development at KNOREX, expressed excitement about the partnership: “We are thrilled to collaborate with a leading data provider that shares our vision of empowering businesses through data-driven marketing. This partnership will provide our customers with unparalleled insights and measurable business impact.”

KNOREX serves a diverse range of industries, including technology, financial services, and healthcare. With this strategic partnership, the company aims to further enhance its position in the rapidly evolving digital advertising landscape.

Comments



Add a public comment...
No comments

No comments yet